BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22679000)

  • 1. CFTR dysfunction predisposes to fibrotic liver disease in a murine model.
    Martin CR; Zaman MM; Ketwaroo GA; Bhutta AQ; Coronel E; Popov Y; Schuppan D; Freedman SD
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G474-81. PubMed ID: 22679000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased peroxisome proliferator activated receptor alpha is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator-/- mice.
    Pall H; Zaman MM; Andersson C; Freedman SD
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):275-81. PubMed ID: 16540796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of colitis in cftr-/- mice results in bile duct injury.
    Blanco PG; Zaman MM; Junaidi O; Sheth S; Yantiss RK; Nasser IA; Freedman SD
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G491-6. PubMed ID: 15064232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.
    Fiorotto R; Scirpo R; Trauner M; Fabris L; Hoque R; Spirli C; Strazzabosco M
    Gastroenterology; 2011 Oct; 141(4):1498-508, 1508.e1-5. PubMed ID: 21712022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
    Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
    Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
    Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
    Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease.
    Lewindon PJ; Pereira TN; Hoskins AC; Bridle KR; Williamson RM; Shepherd RW; Ramm GA
    Am J Pathol; 2002 May; 160(5):1705-15. PubMed ID: 12000722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.
    Kinnman N; Lindblad A; Housset C; Buentke E; Scheynius A; Strandvik B; Hultcrantz R
    Hepatology; 2000 Aug; 32(2):334-40. PubMed ID: 10915740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice.
    Jahnel J; Fickert P; Langner C; Högenauer C; Silbert D; Gumhold J; Fuchsbichler A; Trauner M
    Liver Int; 2009 Oct; 29(9):1316-25. PubMed ID: 19558576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model.
    Durie PR; Kent G; Phillips MJ; Ackerley CA
    Am J Pathol; 2004 Apr; 164(4):1481-93. PubMed ID: 15039235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease.
    Pereira TN; Lewindon PJ; Greer RM; Hoskins AC; Williamson RM; Shepherd RW; Ramm GA
    J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):328-35. PubMed ID: 22157922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered intestinal bile salt biotransformation in a cystic fibrosis (Cftr-/-) mouse model with hepato-biliary pathology.
    Bodewes FA; van der Wulp MY; Beharry S; Doktorova M; Havinga R; Boverhof R; James Phillips M; Durie PR; Verkade HJ
    J Cyst Fibros; 2015 Jul; 14(4):440-6. PubMed ID: 25633479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction.
    Hu S; Russell JO; Liu S; Cao C; McGaughey J; Rai R; Kosar K; Tao J; Hurley E; Poddar M; Singh S; Bell A; Shin D; Raeman R; Singhi AD; Nejak-Bowen K; Ko S; Monga SP
    Elife; 2021 Oct; 10():. PubMed ID: 34609282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
    Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells.
    Cohn JA; Strong TV; Picciotto MR; Nairn AC; Collins FS; Fitz JG
    Gastroenterology; 1993 Dec; 105(6):1857-64. PubMed ID: 7504645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis.
    Rothweiler S; Feldbrügge L; Jiang ZG; Csizmadia E; Longhi MS; Vaid K; Enjyoji K; Popov YV; Robson SC
    Purinergic Signal; 2019 Sep; 15(3):375-385. PubMed ID: 31243614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.
    Joshi N; Kopec AK; Cline-Fedewa H; Luyendyk JP
    Toxicology; 2017 Feb; 377():73-80. PubMed ID: 28049044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline on bile duct ligation induced liver fibrosis in rats.
    Zhang L; Xu LM; Chen YW; Ni QW; Zhou M; Qu CY; Zhang Y
    World J Gastroenterol; 2012 Oct; 18(37):5283-8. PubMed ID: 23066324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.
    Xia JL; Dai C; Michalopoulos GK; Liu Y
    Am J Pathol; 2006 May; 168(5):1500-12. PubMed ID: 16651617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis.
    Beharry S; Ackerley C; Corey M; Kent G; Heng YM; Christensen H; Luk C; Yantiss RK; Nasser IA; Zaman M; Freedman SD; Durie PR
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G839-48. PubMed ID: 17095751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.